SM
YTEN

Sabby Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Sabby Management’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed -$68K – 146
2018
Q3 		$68K Hold
50
– – 0.01% 106
2018
Q2 		$67K Buy
+50
New +$79.3K 0.01% 117
2018
Q1 		– Sell
-224
Closed -$381K – 191
2017
Q4 		$381K Buy
+224
New +$605K 0.03% 108

Other funds holding YTEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Sabby Management's YTEN Position: Q4 2018 in Review

Sabby Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q4 2018, closing a stake of 50 shares — an estimated $68K sold.

Sabby Management first reported a position in YTEN in Q4 2017 and held it in 3 quarters. The position peaked at $381K in Q4 2017. 12 funds tracked by Wall St. Rank hold YTEN as of Q4 2018.

  • Sabby Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Sabby Management sold 50 Yield10 Bioscience, Inc. Common Stock shares in Q4 2018, an estimated $68K.
  • Sabby Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • Sabby Management's Yield10 Bioscience, Inc. Common Stock position peaked at $381K in Q4 2017.
  • 12 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q4 2018.

Based on Sabby Management's 13F filing for Q4 2018, filed 14 Feb 2019.